PPAR-gamma agonist

0 marketed 2 in Phase 3

This page covers all PPAR-gamma agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting PPAR-γ (Peroxisome proliferator-activated receptor gamma), PPAR-gamma.

Targets

PPAR-γ (Peroxisome proliferator-activated receptor gamma) · PPAR-gamma

Phase 3 pipeline (2)

CKD-314+SOC · Chong Kun Dang Pharmaceutical · Endocrinology / Diabetes
CKD-314 is a selective PPAR-gamma agonist that enhances insulin sensitivity and glucose metabolism when combined with standard of care.
CKD-843 dose#2 · Chong Kun Dang Pharmaceutical · Metabolic/Endocrinology
CKD-843 is a selective PPAR-gamma agonist that enhances insulin sensitivity and reduces inflammation.